ESLC.F ESSILORLUXOTTICA 1/2/O.N.
- Market cap
- EUR 83.4B
- P/E
- 34.7x
- P/B
- 2.17x
- ROE
- 6.0%
- Dividend yield
- 0.66%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is ESLC.F undervalued?
Graham numberESLC.F trades 83.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ESSILORLUXOTTICA 1/2/O.N. fundamental analysis
No fundamental analysis for ESSILORLUXOTTICA 1/2/O.N. yet.
ESSILORLUXOTTICA 1/2/O.N. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ESSILORLUXOTTICA 1/2/O.N.
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples…
Full company profileESSILORLUXOTTICA 1/2/O.N. financial statements
ESSILORLUXOTTICA 1/2/O.N. annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 19.8B | 24.5B | 25.4B | 26.5B | 28.5B |
| Gross Profit | 12.2B | 15.6B | 16.0B | 16.8B | 17.3B |
| Operating Income | 2.31B | 3.16B | 3.18B | 3.45B | 3.38B |
| EBITDA | - | 6.11B | 6.12B | 6.59B | 6.60B |
| Net Income | 1.45B | 2.15B | 2.29B | 2.36B | 2.32B |
| EPS | 3.28 | 4.83 | 5.06 | 5.17 | 5.00 |
| Balance Sheet | |||||
| Total Assets | 59.4B | 60.6B | 60.5B | 64.3B | 63.9B |
| Total Liabilities | 23.5B | 22.4B | 21.6B | 23.3B | 24.4B |
| Shareholders' Equity | 35.1B | 37.5B | 38.2B | 40.4B | 38.9B |
| Cash & Short-term Investments | 3.29B | 1.96B | 2.56B | 2.25B | 3.54B |
| Cash Flow | |||||
| Operating Cash Flow | 4.55B | 4.78B | 4.86B | 4.87B | 5.29B |
| Capital Expenditure | 1.03B | 1.57B | 1.53B | 1.52B | 1.53B |
| Free Cash Flow | 3.52B | 3.21B | 3.33B | 3.35B | 3.77B |
| Ratios | |||||
| ROE | 4.1% | 5.7% | 6.0% | 5.8% | 6.0% |
| ROA | 2.4% | 3.6% | 3.8% | 3.7% | 3.6% |
| Net Profit Margin | 7.3% | 8.8% | 9.0% | 8.9% | 8.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ESSILORLUXOTTICA 1/2/O.N. dividends
- Dividend yield
- 0.66%
- Forward dividend
- 2.03 EUR
- Payout ratio
- 23.6%
- Ex-dividend date
- May 11, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 547M | 1.18 | 23.6% |
| 2024 | EUR 1.16B | 2.55 | 49.3% |
| 2023 | EUR 487M | 1.08 | 21.3% |
| 2022 | EUR 454M | 1.02 | 21.1% |
| 2021 | EUR 138M | 0.31 | 9.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns ESSILORLUXOTTICA 1/2/O.N.
- Insiders 0.00%
- Institutions 0.01%
- Public & others 99.99%
- Shares outstanding 917M
- Free float 549M
ESSILORLUXOTTICA 1/2/O.N. company profile
- Company name
- ESSILORLUXOTTICA 1/2/O.N.
- Ticker
- ESLC.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 213,909
- Fiscal year end
- December
- Address
- 1-5 rue Paul Cézanne, Paris, France, 75008
- Phone
- 33 1 49 77 42 24
- Website
- essilorluxottica.com
About ESSILORLUXOTTICA 1/2/O.N.
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands. The company also provides vision assessment, eye pathology diagnosis and treatment, finishing equipment, fitting parameter measurement, small tools, and consumables. In addition, it offers SPECTRALIS, a multimodal imaging platform for diagnosis and treatment; RetinAI; Espansione Group; Cellview Imaging; ANTERION, a multidisciplinary all-in-one anterior segment imaging solution for measurements; apparel, footwear and accessories; and high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. Further, the company designs, develops, markets, and maintains diagnostics, refraction, lens edging and mounting instruments for opticians and prescription laboratories, and measurement; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It sells its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and consumers through the network of brick and mortar retail networks and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.
ESSILORLUXOTTICA 1/2/O.N. management
7- Mr. Francesco MilleriNon-Independent Chairman & CEO · born 1959
- Mr. Paul du SaillantDeputy CEO & Non-Independent Director · born 1959
- Mr. Stefano GrassiChief Financial Officer · born 1973
- Giorgio IannellaHead of Investor Relations
- Mr. Marco CatalaniHead of Corporate Communications
- Mr. Ambati VenuPresident- Greater India · born 1969
- Mr. Ashwin UppalHead of Marketing, Greater India